data_3rdn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3rdn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.831 0.348 . . . . 3.4399999999999999 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -178.23 4.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 3.27 110.388 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.8 134.92 33.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.396 -0.815 . . . . 0.73999999999999999 110.512 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -101.14 163.84 12.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 1.4299999999999999 110.202 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -85.62 123.55 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.57 -0.706 . . . . 0.67000000000000004 110.342 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 t -128.94 131.56 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.723 -0.611 . . . . 0.56000000000000005 109.651 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.29 122.64 16.16 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.422 -0.799 . . . . 0.46999999999999997 110.241 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -73.0 -43.4 62.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.713 . . . . 1.96 110.285 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -101.75 -178.1 3.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 1.3899999999999999 110.522 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 tt -99.96 125.24 45.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.56 -0.712 . . . . 1.02 109.867 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -124.26 144.05 44.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 1.6699999999999999 109.983 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.16 -168.44 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.791 1.416 . . . . 0.78000000000000003 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -75.67 150.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.494 -0.754 . . . . 1.7 109.863 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 54.92 63.54 2.1 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.416 0.627 . . . . 2.3799999999999999 110.71 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.4 m -125.76 129.93 50.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.68000000000000005 109.673 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.61 142.15 57.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.56000000000000005 110.274 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -98.0 148.99 22.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.68999999999999995 110.535 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.7 p -130.48 168.68 16.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.523 -0.736 . . . . 0.66000000000000003 110.221 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.09 -45.21 89.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.513 -0.742 . . . . 1.24 110.548 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mt -64.63 -22.63 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.604 -0.685 . . . . 0.98999999999999999 110.477 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.9 mtt -83.75 -47.68 10.91 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.314 -0.866 . . . . 1.45 110.375 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 49.3 mtm -76.97 124.57 27.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.493 -0.754 . . . . 3.6899999999999999 110.23 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -113.08 125.33 54.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.699 -0.625 . . . . 2.5 110.324 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.94 80.25 9.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.80000000000000004 109.785 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -113.31 147.27 37.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 110.426 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -85.36 84.77 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.564 -0.71 . . . . 0.90000000000000002 109.428 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.72 160.84 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.491 -0.756 . . . . 1.1200000000000001 110.391 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 p -99.68 153.41 37.79 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 1.9099999999999999 110.422 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.9 164.2 87.87 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.777 -2.176 . . . . 1.54 111.074 -0.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.77 100.21 10.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.675 -0.64 . . . . 3.1200000000000001 110.051 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.25 -121.41 1.07 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.591 -1.404 . . . . 1.0700000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mt -90.7 136.24 28.16 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.477 -1.013 . . . . 1.3 109.591 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 175.82 8.18 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.788 1.415 . . . . 1.4199999999999999 110.62 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.43 34.04 0.75 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.377 -0.827 . . . . 0.90000000000000002 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -77.23 -48.87 16.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.207 -0.933 . . . . 3.0 110.449 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -101.3 34.9 2.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.57 -0.707 . . . . 2.7799999999999998 110.611 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -52.12 -54.51 40.41 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.05 -1.031 . . . . 1.1899999999999999 110.836 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.46 -22.6 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.525 1.276 . . . . 0.87 111.019 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.355 -0.841 . . . . 1.9199999999999999 110.032 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -61.82 -27.78 69.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.584 -0.698 . . . . 2.3599999999999999 110.186 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.19 136.28 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 0.66000000000000003 110.299 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.1 -42.92 1.8 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.472 -1.051 . . . . 0.78000000000000003 110.472 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.25 156.7 38.31 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.219 -1.165 . . . . 2.48 110.783 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -107.95 167.33 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.556 -0.715 . . . . 1.5600000000000001 110.657 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -107.69 171.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.647 -0.658 . . . . 0.66000000000000003 110.652 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -101.01 -21.05 15.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.503 -0.748 . . . . 1.6799999999999999 110.842 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -109.44 173.99 6.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.347 -0.846 . . . . 3.1299999999999999 110.594 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.21 142.62 28.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.766 . . . . 0.60999999999999999 109.957 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.0 t -126.51 101.55 27.36 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.483 -0.761 . . . . 0.75 110.116 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.32 -168.48 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.792 1.417 . . . . 0.87 111.282 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.95 140.57 50.96 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.351 -0.843 . . . . 0.78000000000000003 111.516 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.98 36.64 93.15 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.088 -0.805 . . . . 0.69999999999999996 111.088 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 m -98.09 120.51 38.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.308 -1.113 . . . . 0.92000000000000004 110.176 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 t -66.31 153.45 42.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.501 -0.749 . . . . 1.4199999999999999 110.34 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.59 116.78 12.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.537 -0.727 . . . . 1.76 110.176 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.4 mtt -99.83 153.95 37.5 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.455 -0.778 . . . . 2.1499999999999999 110.439 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.8 -40.0 4.06 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.926 1.487 . . . . 1.1599999999999999 110.818 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -69.43 -26.31 64.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.517 -0.739 . . . . 2.27 110.525 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtt -72.79 -29.45 63.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.522 -0.736 . . . . 1.6499999999999999 110.65 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.3 t -81.35 135.03 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.272 -0.892 . . . . 1.0 110.42 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.94 -68.59 0.67 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.642 -0.661 . . . . 4.1799999999999997 109.665 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -101.64 96.75 7.31 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.597 -0.69 . . . . 3.1000000000000001 110.283 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 136.44 57.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.251 -0.906 . . . . 3.0499999999999998 110.604 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -80.92 -27.88 36.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.72 . . . . 3.0699999999999998 110.762 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.01 101.45 9.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 3.79 109.377 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.34 62.38 3.15 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.823 -1.311 . . . . 3.3900000000000001 109.823 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -92.09 -84.59 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.631 -0.923 . . . . 4.4199999999999999 110.349 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.8 p -111.14 -78.43 0.59 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.107 -0.995 . . . . 3.2999999999999998 110.696 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -75.09 -53.43 2.86 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.483 -0.761 . . . . 3.8500000000000001 111.281 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.74 153.65 59.23 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.437 1.23 . . . . 2.3300000000000001 110.741 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.85 -100.25 0.2 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.909 -1.276 . . . . 2.1099999999999999 109.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.94 141.23 36.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.534 -0.98 . . . . 4.5999999999999996 110.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 pttm . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.648 -0.691 . . . . 5.75 111.026 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.831 0.348 . . . . 3.4399999999999999 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -178.23 4.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 3.27 110.388 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.8 134.92 33.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.396 -0.815 . . . . 0.73999999999999999 110.512 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -101.14 163.84 12.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 1.4299999999999999 110.202 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG22 HD11 ' A' ' 37' ' ' ILE . 89.5 t -85.62 123.55 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.57 -0.706 . . . . 0.67000000000000004 110.342 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 18.8 t -128.94 131.56 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.723 -0.611 . . . . 0.56000000000000005 109.651 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.29 122.64 16.16 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.422 -0.799 . . . . 0.46999999999999997 110.241 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -73.0 -43.4 62.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.713 . . . . 1.96 110.285 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -101.75 -178.1 3.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 1.3899999999999999 110.522 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -99.96 125.24 45.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.56 -0.712 . . . . 1.02 109.867 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.505 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.2 pt -124.26 144.05 44.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 1.6699999999999999 109.983 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.16 -168.44 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.791 1.416 . . . . 0.78000000000000003 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 46' ' ' ASN . 3.1 mt -75.67 150.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.494 -0.754 . . . . 1.7 109.863 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 54.92 63.54 2.1 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.416 0.627 . . . . 2.3799999999999999 110.71 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.4 m -125.76 129.93 50.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.68000000000000005 109.673 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.61 142.15 57.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.56000000000000005 110.274 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -98.0 148.99 22.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.68999999999999995 110.535 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.537 ' HA ' HG22 ' A' ' 41' ' ' VAL . 26.7 p -130.48 168.68 16.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.523 -0.736 . . . . 0.66000000000000003 110.221 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.09 -45.21 89.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.513 -0.742 . . . . 1.24 110.548 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mt -64.63 -22.63 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.604 -0.685 . . . . 0.98999999999999999 110.477 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.9 mtt -83.75 -47.68 10.91 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.314 -0.866 . . . . 1.45 110.375 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HE3' HG23 ' A' ' 41' ' ' VAL . 49.3 mtm -76.97 124.57 27.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.493 -0.754 . . . . 3.6899999999999999 110.23 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -113.08 125.33 54.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.699 -0.625 . . . . 2.5 110.324 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.94 80.25 9.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.80000000000000004 109.785 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -113.31 147.27 37.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 110.426 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -85.36 84.77 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.564 -0.71 . . . . 0.90000000000000002 109.428 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.72 160.84 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.491 -0.756 . . . . 1.1200000000000001 110.391 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 23.2 p -99.68 153.41 37.79 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 1.9099999999999999 110.422 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.6 Cg_endo -76.9 164.2 87.87 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.777 -2.176 . . . . 1.54 111.074 -0.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.77 100.21 10.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.675 -0.64 . . . . 3.1200000000000001 110.051 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.25 -121.41 1.07 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.591 -1.404 . . . . 1.0700000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 55' ' ' LEU . 4.5 mt -90.7 136.24 28.16 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.477 -1.013 . . . . 1.3 109.591 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 175.82 8.18 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.788 1.415 . . . . 1.4199999999999999 110.62 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -88.43 34.04 0.75 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.377 -0.827 . . . . 0.90000000000000002 111.023 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -77.23 -48.87 16.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.207 -0.933 . . . . 3.0 110.449 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -101.3 34.9 2.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.57 -0.707 . . . . 2.7799999999999998 110.611 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 5' ' ' VAL . 3.0 mm -52.12 -54.51 40.41 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.05 -1.031 . . . . 1.1899999999999999 110.836 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.46 -22.6 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.525 1.276 . . . . 0.87 111.019 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.355 -0.841 . . . . 1.9199999999999999 110.032 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' HG3' ' A' ' 64' ' ' GLU . 2.6 mt -61.82 -27.78 69.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.584 -0.698 . . . . 2.3599999999999999 110.186 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HE3' ' A' ' 22' ' ' MET . 1.1 t -54.19 136.28 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 0.66000000000000003 110.299 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.1 -42.92 1.8 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.472 -1.051 . . . . 0.78000000000000003 110.472 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.25 156.7 38.31 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.219 -1.165 . . . . 2.48 110.783 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -107.95 167.33 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.556 -0.715 . . . . 1.5600000000000001 110.657 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -107.69 171.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.647 -0.658 . . . . 0.66000000000000003 110.652 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 13' ' ' ILE . 3.2 t30 -101.01 -21.05 15.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.503 -0.748 . . . . 1.6799999999999999 110.842 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' A' ' 59' ' ' MET . 71.9 mtt-85 -109.44 173.99 6.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.347 -0.846 . . . . 3.1299999999999999 110.594 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.21 142.62 28.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.766 . . . . 0.60999999999999999 109.957 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 11' ' ' ILE . 81.0 t -126.51 101.55 27.36 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.483 -0.761 . . . . 0.75 110.116 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 42.2 Cg_endo -70.32 -168.48 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.792 1.417 . . . . 0.87 111.282 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -70.95 140.57 50.96 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.351 -0.843 . . . . 0.78000000000000003 111.516 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.98 36.64 93.15 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.088 -0.805 . . . . 0.69999999999999996 111.088 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.496 ' CG2' HG13 ' A' ' 49' ' ' VAL . 40.4 m -98.09 120.51 38.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.308 -1.113 . . . . 0.92000000000000004 110.176 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 29' ' ' PRO . 15.2 t -66.31 153.45 42.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.501 -0.749 . . . . 1.4199999999999999 110.34 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.59 116.78 12.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.537 -0.727 . . . . 1.76 110.176 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.4 mtt -99.83 153.95 37.5 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.455 -0.778 . . . . 2.1499999999999999 110.439 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.8 -40.0 4.06 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.926 1.487 . . . . 1.1599999999999999 110.818 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -69.43 -26.31 64.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.517 -0.739 . . . . 2.27 110.525 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 38.7 mtt -72.79 -29.45 63.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.522 -0.736 . . . . 1.6499999999999999 110.65 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.3 t -81.35 135.03 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.272 -0.892 . . . . 1.0 110.42 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.94 -68.59 0.67 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.642 -0.661 . . . . 4.1799999999999997 109.665 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -101.64 96.75 7.31 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.597 -0.69 . . . . 3.1000000000000001 110.283 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 136.44 57.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.251 -0.906 . . . . 3.0499999999999998 110.604 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HG3' HD22 ' A' ' 40' ' ' LEU . 8.3 mt-10 -80.92 -27.88 36.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.72 . . . . 3.0699999999999998 110.762 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.01 101.45 9.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 3.79 109.377 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.34 62.38 3.15 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.823 -1.311 . . . . 3.3900000000000001 109.823 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 HG23 ' A' ' 68' ' ' THR . 91.2 m -92.09 -84.59 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.631 -0.923 . . . . 4.4199999999999999 110.349 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 67' ' ' THR . 12.8 p -111.14 -78.43 0.59 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.107 -0.995 . . . . 3.2999999999999998 110.696 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 m -75.09 -53.43 2.86 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.483 -0.761 . . . . 3.8500000000000001 111.281 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -71.74 153.65 59.23 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.437 1.23 . . . . 2.3300000000000001 110.741 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.85 -100.25 0.2 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.909 -1.276 . . . . 2.1099999999999999 109.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.94 141.23 36.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.534 -0.98 . . . . 4.5999999999999996 110.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 pttm . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.648 -0.691 . . . . 5.75 111.026 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 120.831 0.348 . . . . 3.4399999999999999 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 -178.23 4.67 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.486 -0.759 . . . . 3.27 110.388 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.8 134.92 33.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.396 -0.815 . . . . 0.73999999999999999 110.512 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -101.14 163.84 12.09 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.76 -0.587 . . . . 1.4299999999999999 110.202 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG22 HD11 ' A' ' 37' ' ' ILE . 89.5 t -85.62 123.55 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.57 -0.706 . . . . 0.67000000000000004 110.342 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 18.8 t -128.94 131.56 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.723 -0.611 . . . . 0.56000000000000005 109.651 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.29 122.64 16.16 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.422 -0.799 . . . . 0.46999999999999997 110.241 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -73.0 -43.4 62.21 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.56 -0.713 . . . . 1.96 110.285 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -101.75 -178.1 3.62 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 1.3899999999999999 110.522 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 50' ' ' PRO . 6.2 tt -99.96 125.24 45.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.56 -0.712 . . . . 1.02 109.867 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.505 HG13 ' HB ' ' A' ' 49' ' ' VAL . 1.2 pt -124.26 144.05 44.54 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.524 -0.735 . . . . 1.6699999999999999 109.983 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.16 -168.44 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.791 1.416 . . . . 0.78000000000000003 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.434 HG23 ' O ' ' A' ' 46' ' ' ASN . 3.1 mt -75.67 150.79 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.494 -0.754 . . . . 1.7 109.863 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 54.92 63.54 2.1 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.416 0.627 . . . . 2.3799999999999999 110.71 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.4 m -125.76 129.93 50.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.569 -0.707 . . . . 0.68000000000000005 109.673 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.61 142.15 57.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.56000000000000005 110.274 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.3 mt -98.0 148.99 22.92 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.68999999999999995 110.535 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.537 ' HA ' HG22 ' A' ' 41' ' ' VAL . 26.7 p -130.48 168.68 16.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.523 -0.736 . . . . 0.66000000000000003 110.221 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.09 -45.21 89.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.513 -0.742 . . . . 1.24 110.548 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mt -64.63 -22.63 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.604 -0.685 . . . . 0.98999999999999999 110.477 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.9 mtt -83.75 -47.68 10.91 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.314 -0.866 . . . . 1.45 110.375 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HE3' HG23 ' A' ' 41' ' ' VAL . 49.3 mtm -76.97 124.57 27.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.493 -0.754 . . . . 3.6899999999999999 110.23 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -113.08 125.33 54.26 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.699 -0.625 . . . . 2.5 110.324 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.94 80.25 9.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.495 -0.753 . . . . 0.80000000000000004 109.785 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -113.31 147.27 37.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.519 -0.738 . . . . 1.8500000000000001 110.426 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.6 t -85.36 84.77 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.564 -0.71 . . . . 0.90000000000000002 109.428 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 m -137.72 160.84 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.491 -0.756 . . . . 1.1200000000000001 110.391 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HA ' ' C ' ' A' ' 29' ' ' PRO . 23.2 p -99.68 153.41 37.79 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 1.9099999999999999 110.422 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HG2' HG21 ' A' ' 54' ' ' THR . 47.6 Cg_endo -76.9 164.2 87.87 Favored 'Cis proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.777 -2.176 . . . . 1.54 111.074 -0.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 41.9 mtm -82.77 100.21 10.14 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.675 -0.64 . . . . 3.1200000000000001 110.051 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.25 -121.41 1.07 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.591 -1.404 . . . . 1.0700000000000001 109.591 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 55' ' ' LEU . 4.5 mt -90.7 136.24 28.16 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.477 -1.013 . . . . 1.3 109.591 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 175.82 8.18 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.788 1.415 . . . . 1.4199999999999999 110.62 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' HA ' HG12 ' A' ' 37' ' ' ILE . . . -88.43 34.04 0.75 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.377 -0.827 . . . . 0.90000000000000002 111.023 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -77.23 -48.87 16.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.207 -0.933 . . . . 3.0 110.449 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -101.3 34.9 2.41 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.57 -0.707 . . . . 2.7799999999999998 110.611 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.622 HD11 HG22 ' A' ' 5' ' ' VAL . 3.0 mm -52.12 -54.51 40.41 Favored Pre-proline 0 N--CA 1.503 2.181 0 O-C-N 121.05 -1.031 . . . . 1.1899999999999999 110.836 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 44.4 Cg_endo -71.46 -22.6 24.63 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.525 1.276 . . . . 0.87 111.019 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.355 -0.841 . . . . 1.9199999999999999 110.032 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' HG3' ' A' ' 64' ' ' GLU . 2.6 mt -61.82 -27.78 69.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.584 -0.698 . . . . 2.3599999999999999 110.186 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.728 HG23 ' HE3' ' A' ' 22' ' ' MET . 1.1 t -54.19 136.28 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 0.66000000000000003 110.299 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.1 -42.92 1.8 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 110.472 -1.051 . . . . 0.78000000000000003 110.472 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -69.25 156.7 38.31 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.219 -1.165 . . . . 2.48 110.783 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -107.95 167.33 10.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.556 -0.715 . . . . 1.5600000000000001 110.657 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -107.69 171.75 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.647 -0.658 . . . . 0.66000000000000003 110.652 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.434 ' O ' HG23 ' A' ' 13' ' ' ILE . 3.2 t30 -101.01 -21.05 15.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.503 -0.748 . . . . 1.6799999999999999 110.842 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB2' ' HG2' ' A' ' 59' ' ' MET . 71.9 mtt-85 -109.44 173.99 6.07 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.347 -0.846 . . . . 3.1299999999999999 110.594 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.21 142.62 28.47 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.475 -0.766 . . . . 0.60999999999999999 109.957 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 11' ' ' ILE . 81.0 t -126.51 101.55 27.36 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.483 -0.761 . . . . 0.75 110.116 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HA ' ' HG ' ' A' ' 10' ' ' LEU . 42.2 Cg_endo -70.32 -168.48 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.792 1.417 . . . . 0.87 111.282 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 10' ' ' LEU . 0.4 OUTLIER -70.95 140.57 50.96 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.351 -0.843 . . . . 0.78000000000000003 111.516 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.98 36.64 93.15 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 111.088 -0.805 . . . . 0.69999999999999996 111.088 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.496 ' CG2' HG13 ' A' ' 49' ' ' VAL . 40.4 m -98.09 120.51 38.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.308 -1.113 . . . . 0.92000000000000004 110.176 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 29' ' ' PRO . 15.2 t -66.31 153.45 42.59 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.501 -0.749 . . . . 1.4199999999999999 110.34 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -71.59 116.78 12.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.537 -0.727 . . . . 1.76 110.176 -179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 8.4 mtt -99.83 153.95 37.5 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.455 -0.778 . . . . 2.1499999999999999 110.439 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.8 -40.0 4.06 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.926 1.487 . . . . 1.1599999999999999 110.818 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -69.43 -26.31 64.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.517 -0.739 . . . . 2.27 110.525 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 47' ' ' ARG . 38.7 mtt -72.79 -29.45 63.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.522 -0.736 . . . . 1.6499999999999999 110.65 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.3 t -81.35 135.03 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.272 -0.892 . . . . 1.0 110.42 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.94 -68.59 0.67 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.642 -0.661 . . . . 4.1799999999999997 109.665 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -101.64 96.75 7.31 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.597 -0.69 . . . . 3.1000000000000001 110.283 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 136.44 57.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.251 -0.906 . . . . 3.0499999999999998 110.604 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HG3' HD22 ' A' ' 40' ' ' LEU . 8.3 mt-10 -80.92 -27.88 36.02 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.549 -0.72 . . . . 3.0699999999999998 110.762 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.01 101.45 9.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.265 -0.897 . . . . 3.79 109.377 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -90.34 62.38 3.15 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.823 -1.311 . . . . 3.3900000000000001 109.823 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 HG22 HG23 ' A' ' 68' ' ' THR . 91.2 m -92.09 -84.59 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.631 -0.923 . . . . 4.4199999999999999 110.349 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 67' ' ' THR . 12.8 p -111.14 -78.43 0.59 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.107 -0.995 . . . . 3.2999999999999998 110.696 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 m -75.09 -53.43 2.86 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.483 -0.761 . . . . 3.8500000000000001 111.281 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 69' ' ' SER . 45.0 Cg_endo -71.74 153.65 59.23 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 O-C-N 123.437 1.23 . . . . 2.3300000000000001 110.741 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.85 -100.25 0.2 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.909 -1.276 . . . . 2.1099999999999999 109.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.94 141.23 36.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.534 -0.98 . . . . 4.5999999999999996 110.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 pttm . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 118.648 -0.691 . . . . 5.75 111.026 179.897 . . . . . . . . 0 0 . 1 stop_ save_